Endothelial Growth Factors
"Endothelial Growth Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
These growth factors are soluble mitogens secreted by a variety of organs. The factors are a mixture of two single chain polypeptides which have affinity to heparin. Their molecular weight are organ and species dependent. They have mitogenic and chemotactic effects and can stimulate endothelial cells to grow and synthesize DNA. The factors are related to both the basic and acidic FIBROBLAST GROWTH FACTORS but have different amino acid sequences.
| Descriptor ID |
D016228
|
| MeSH Number(s) |
D12.644.276.390 D12.776.467.390 D23.529.390
|
| Concept/Terms |
Endothelial Growth Factors- Endothelial Growth Factors
- Growth Factors, Endothelial
- Endo-GF
- Endothelial Growth Factor Polypeptides
- Endothelial Growth Factor
- Growth Factor, Endothelial
- ECDGF
- Endothelial Cell-Derived Growth Factors
- Endothelial Cell Derived Growth Factors
|
Below are MeSH descriptors whose meaning is more general than "Endothelial Growth Factors".
Below are MeSH descriptors whose meaning is more specific than "Endothelial Growth Factors".
This graph shows the total number of publications written about "Endothelial Growth Factors" by people in this website by year, and whether "Endothelial Growth Factors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 2 | 3 |
| 2003 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Endothelial Growth Factors" by people in Profiles.
-
One-year follow-up of direct myocardial gene transfer of vascular endothelial growth factor-2 using naked plasmid deoxyribonucleic acid by way of thoracotomy in no-option patients. Am J Cardiol. 2003 Aug 15; 92(4):436-9.
-
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003 Mar; 111(5):649-58.
-
Evidence for different aetiologies of low estradiol response to FSH: age-related accelerated luteinization of follicles or presence of ovarian autoantibodies. Hum Reprod. 2002 Oct; 17(10):2641-9.
-
Differential expression of vascular endothelial growth factor-A (VEGF-A) and VEGF-B after brain injury. J Neuropathol Exp Neurol. 2002 Sep; 61(9):778-88.
-
The blood-brain barrier and cerebral angiogenesis: lessons from the cold-injury model. Trends Mol Med. 2002 Jan; 8(1):38-44.
-
The clinical and biological effects of thalidomide in patients with myelodysplastic syndromes. Br J Haematol. 2001 Dec; 115(4):881-94.
-
Do angiogenesis and growth factor expression predict prognosis of esophageal cancer? Am Surg. 2000 Apr; 66(4):401-5; discussion 405-6.